Using Blood Pressure Values to Decrease Postpartum Readmissions
Evaluation of different blood pressure assessment strategies and cutoff values to predict postpartum hypertension-related readmissions: a retrospective cohort study
Postpartum hypertension (high blood pressure in the first 42 days after delivery) is the leading reason for readmission to the hospital after a delivery stay. Current guidelines recommend starting medicines to lower blood pressure when a woman’s postpartum measurements are 150/100mmHg or higher on at least 2 occasions at least 4 hours apart in the first 4 days following delivery. However, these recommendations are largely based on expert opinion. In this study, researchers asked how well the blood pressure cutoff of 150/100mmHg can predict a patient needing to be readmitted for high blood pressure problems postpartum. The researchers analyzed a dataset of nearly 25,000 women and found that a blood pressure cutoff of measurements 140/90mmHg or higher was the most reliable predictor of postpartum readmissions for high blood pressure problems. Next steps should be to conduct more studies to test these new blood pressure cutoffs and determine if starting blood pressure lowering medicines at lower blood pressures can in fact help postpartum women avoid being readmitted to the hospital.
LINK: https://pubmed.ncbi.nlm.nih.gov/33451628/
About Research Roundup
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Hypertensive disorders of pregnancy significantly increase your risk of developing long-term heart problems. A careful review of blood pressure elevations during and after pregnancy may assist in iden...
Hypertensive disorders of pregnancy (HDP) can affect different groups of women in different ways, and even though we know this happening, we don't fully understand why. There are many factors, like bi...
There is growing evidence that studies examining pregnancy and its complications need to start early within the pregnancy to fully understand the nature of preeclampsia. Key gestational milestones, wh...
It is known that chronic hypertension and high BMI (body mass index) are risk factors for hypertensive disorders of pregnancy (HDP). Studies documenting this risk have usually assessed blood pre...
Several biomarker tests are under development to predict or diagnose preeclampsia. While none of these tests are yet widely accepted in U.S. clinical practice, two FDA-approved tests are available in...